Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The procedure entails thorough molecular simulations of the catalytic and allosteric binding pockets, accompanied by ensemble virtual screening that factors in their conformational flexibility. When developing modulators, the structural modifications brought about by reaction intermediates are factored in to optimize activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P09488
UPID:
GSTM1_HUMAN
Alternative names:
GST HB subunit 4; GST class-mu 1; GSTM1-1; GSTM1a-1a; GSTM1b-1b; GTH4
Alternative UPACC:
P09488; Q5GHG0; Q6FH88; Q8TC98; Q9UC96
Background:
Glutathione S-transferase Mu 1 (GST Mu 1), known by alternative names such as GST HB subunit 4 and GSTM1-1, plays a crucial role in detoxifying cells. It achieves this by conjugating reduced glutathione to a variety of hydrophobic electrophiles, including prostaglandin A2 and J2. This protein is also involved in the formation of novel hepoxilin regioisomers, showcasing its versatility in cellular processes.
Therapeutic significance:
Understanding the role of Glutathione S-transferase Mu 1 could open doors to potential therapeutic strategies. Its pivotal function in detoxification and metabolism positions it as a key target for drug discovery, aiming to enhance cellular resilience against toxic compounds.